First Wave BioPharma, Inc. FWBI

$FWBI ➡️ $GRI ????

First Wave BioPharma, Inc. (NASDAQ: FWBI) announced an agreement with Sanofi (NASDAQ: SNY) to license Capeserod, a selective 5-HT4 receptor partial agonist, for gastrointestinal (GI) indications. Under the terms of the agreement, First Wave will receive from Sanofi an exclusive, global license for Capeserod and will assume responsibility for all future clinical development.

First Wave BioPharma, Inc. (NASDAQ: FWBI) announced an agreement with Sanofi (NASDAQ: SNY) to license Capeserod, a selective 5-HT4 receptor partial agonist, for gastrointestinal (GI) indications. Under the terms of the agreement, First Wave will receive from Sanofi an exclusive, global license for Capeserod and will assume responsibility for all future clinical development.

First Wave BioPharma, Inc. (NASDAQ: FWBI) announced an agreement with Sanofi (NASDAQ: SNY) to license Capeserod, a selective 5-HT4 receptor partial agonist, for gastrointestinal (GI) indications. Under the terms of the agreement, First Wave will receive from Sanofi an exclusive, global license for Capeserod and will assume responsibility for all future clinical development.

First Wave BioPharma, Inc. (NASDAQ: FWBI) announced an agreement with Sanofi (NASDAQ: SNY) to license Capeserod, a selective 5-HT4 receptor partial agonist, for gastrointestinal (GI) indications. Under the terms of the agreement, First Wave will receive from Sanofi an exclusive, global license for Capeserod and will assume responsibility for all future clinical development.

$IBIO ?????

$FWBI when ???

$FWBI wtf is going here????

$FWBI abaou to explode nano float

$FWBI volume come in ?